0.0001
0.0000
(0.00%)
At close: January 23 at 7:00:00 PM EST
Key Executives
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Brian S. Payne | CEO, CFO, VP, Secretary & Chairman of the Board | 31.2k | -- | 1968 |
| Mr. Harold Andre Aubrey De Lavenu | VP & Independent Director | 31.31k | -- | 1964 |
CEN Biotech, Inc.
3295 Quality Way
Suite 300
Windsor, ON N8T 3R9
Canada
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 4
Description
CEN Biotech, Inc. focuses on the manufacture, production, and development of light emitting diode lighting technology and hemp-based products. It intends to cultivate hemp for usage in industrial, medical, and food products; and to provide digital marketing and web design related services. The company was incorporated in 2013 and is based in Windsor, Canada.
Corporate Governance
CEN Biotech, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
April 12, 2023 at 12:00 AM UTC
15-12G: Notice of termination of registration of a class of securities under Section 12(g)